1. Home
  2. TAYD vs IMUX Comparison

TAYD vs IMUX Comparison

Compare TAYD & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Taylor Devices Inc.

TAYD

Taylor Devices Inc.

HOLD

Current Price

$55.70

Market Cap

193.6M

Sector

Industrials

ML Signal

HOLD

Logo Immunic Inc.

IMUX

Immunic Inc.

HOLD

Current Price

$7.40

Market Cap

155.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TAYD
IMUX
Founded
1955
2016
Country
United States
United States
Employees
N/A
66
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
193.6M
155.8M
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
TAYD
IMUX
Price
$55.70
$7.40
Analyst Decision
Strong Buy
Analyst Count
0
12
Target Price
N/A
★ $43.09
AVG Volume (30 Days)
36.6K
★ 382.7K
Earning Date
10-02-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 38.00
EPS
★ 0.14
N/A
Revenue
★ $41,649,673.00
N/A
Revenue This Year
$25.09
N/A
Revenue Next Year
$23.22
N/A
P/E Ratio
$403.00
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$43.14
$0.51
52 Week High
$90.37
$17.43

Technical Indicators

Market Signals
Indicator
TAYD
IMUX
Relative Strength Index (RSI) 44.85 36.21
Support Level $51.63 $6.35
Resistance Level $59.69 $8.60
Average True Range (ATR) 1.89 0.65
MACD -0.20 0.19
Stochastic Oscillator 42.70 46.67

Price Performance

Historical Comparison
TAYD
IMUX

About TAYD Taylor Devices Inc.

Taylor Devices Inc is engaged in the design, development, manufacture and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment and structures. The company continues to develop new and technology products. The company manufactures and sells a group of very similar products that have many different applications for customers. These similar products are included in one of nine categories, namely, Seismic Dampers, Fluidicshoks, Crane and Industrial Buffers, Self-Adjusting Shock Absorbers, Liquid Die Springs, Vibration Dampers, Machined Springs, Custom Shock and Vibration Isolators, and Custom Actuators. It has presence in USA, Asia, and Others. Majority of revenue comes from USA.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.

Share on Social Networks: